Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TNF Pharmaceuticals Inc TNFA

Healthcare
TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on developing novel therapies for age-related diseases and autoimmune and inflammatory conditions. It is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets: MYMD-1 and Supera-CBD. MYMD-1 is a drug platform based on a... see more

Recent & Breaking News (NDAQ:TNFA)

Akers Biosciences Updates on Akers Wellness(TM) Tests

Marketwired April 24, 2017

Akers Biosciences Reports Earnings for Fiscal Year 2016

Marketwired April 11, 2017

Akers Biosciences Announces Conference Call to Discuss FY 2016 Earnings

Marketwired April 10, 2017

Akers Biosciences to Commercialize Heparin PF4 Rapid Test in Puerto Rico

Marketwired April 10, 2017

Akers Biosciences Announces a $2 Million Private Placement

Marketwired March 30, 2017

Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016

Marketwired March 30, 2017

Akers Biosciences Announces Conference Call to Discuss FY 2016 Earnings

Marketwired March 29, 2017

20 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  March 28, 2017

Mid-Day Market Update: Exeter Gains On Acquisition News; CryoPort Shares Slide

Benzinga.com  March 28, 2017

Mid-Morning Market Update: Markets Rise; Carnival Profit Beats Estimates

Benzinga.com  March 28, 2017

Akers Biosciences Begins Selling Rapid Cholesterol Test through Distribution Agreement with First Check

Marketwired March 28, 2017

18 Biggest Mid-Day Gainers For Thursday

Benzinga.com  February 16, 2017

Akers Biosciences Allowed US Patent for Akers Wellness(TM) Tests Cartridge

Marketwired February 16, 2017

Akers Biosciences Announces Closing of Public Offering

Marketwired January 13, 2017

Mid-Day Market Update: Dow Gains Over 50 Points; hhgregg Shares Plunge

Benzinga.com  January 10, 2017

Akers Biosciences Announces Pricing of Public Offering of 1,667,000 Shares and 833,500 Warrants

Marketwired January 9, 2017

Akers Biosciences Signs 3-year Agreement with GNYHA Services for Heparin PF4 Rapid Test

Marketwired December 22, 2016

Cognizant Becomes Exclusive Provider of Digital Systems, Technology and Operations Services to Multiple Aker Group Industrial Portfolio Companies

Canada NewsWire December 20, 2016

Akers Biosciences Signs 3-year Agreement with Greater New York Hospital Association for Heparin PF4 Rapid Test

Marketwired December 19, 2016

Akers Biosciences Signs Distribution Agreement with First Check Diagnostics for Rapid Cholesterol Test

Marketwired December 1, 2016